Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
2.
Sayed RH, Wechalekar AD, Gilbertson JA, Bass P, Mahmood S, Sachchithanantham S, Fontana M et al (2015) Natural history and outcome of light chain deposition disease. Blood 126(26):2805–2810CrossRefPubMedPubMedCentral
3.
Nasr Samih H, Valeri Anthony M, Cornell Lynn D, Fidler Mary E et al (2012) Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol 7(2):231–239CrossRefPubMed
4.
Matthai SM, Jacob S, Devasia AJ, Bindra M, David VG, Varughese S (2018) Unmasking and successful management of light chain deposition disease of kidney in pregnancy: a complex case, mirroring the complex needs of pregnancy with kidney disease in India. J Nephrol 31(5):785–791CrossRefPubMed
5.
Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadjikonstantinou V, Dimopoulos MA (2009) Treatment of light chain deposition disease with bortezomib and dexamethasone. Haematologica 94:300–302CrossRefPubMed
6.
Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR et al (2008) Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Nephrol Dial Transpl 23(6):2052–2057CrossRef
Metadata
Title
Treatment and Outcome of Light Chain Deposition Disease in the Era of Novel Agents and Transplant
Authors
Priyanka Moule
Deepika Gupta
Chetan Agarwal
Pallav Gupta
Jyoti Kotwal
Nitin Gupta
Publication date
21-07-2023
Publisher
Springer India
Keyword
Dexamethasone
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2024
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-023-01681-y

Other articles of this Issue 1/2024

Indian Journal of Hematology and Blood Transfusion 1/2024 Go to the issue

ORIGINAL ARTICLE

Cytomegalovirus Reactivation as a Risk Factor for All-Cause Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation: Experience Over Two Decades from a Tertiary Referral Center in India

ORIGINAL ARTICLE

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

ORIGINAL ARTICLE

COVID-19 Vaccine Uptake in Patients with Multiple Myeloma and AL Amyloidosis: A Cross-Sectional Observational Study from India

ORIGINAL ARTICLE

CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country

REVIEW ARTICLE

Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings

SHORT COMMUNICATION

HIV Associated Lymphomas: A Double-Edged Sword
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits